Business

Stay updated with the latest business news, market trends, expert insights, and industry updates to help you stay ahead in the competitive world of business.

Latest Posts

Pharmaceutical Industry and PBMs Clash Over Patient Savings and Drug Costs

CVS, PFE, GDRX, LLY, HIMS stocks surge as pharma battle with PBMs heats up in Washington. Amid scrutiny, CVS Health defends its role in reducing drug costs, citing 90% generic prescriptions and $8 average out-of-pocket costs.

Lenovo Q3 Revenue Jumps 20% Amidst Modest PC Market Recovery

Lenovo's Q3 revenue surges 20%, driven by global PC recovery and AI demand. The company maintains its position as the largest PC vendor with a 24.5% market share and diversifies into software, services, and AI solutions.

Lenovo Q4 Profit Buoyed by AI Infrastructure Demand, Beating Estimates

Lenovo's quarterly profit beats projections, driven by AI infrastructure spending and PC market recovery. Investors bet on AI PCs and government subsidies boosting demand, while potential tariffs and economic challenges remain.

Dixon Technologies set to double revenue as India electronics manufacturing booms

Dixon Technologies, Google’s Pixel smartphone assembler, expects to double its revenue this fiscal year driven by growth in local electronics manufacturing.

KKR Wins Fuji Soft Battle With 57.92% Stake

KKR acquires 57.92% of Fuji Soft, ending a fierce battle with Bain Capital. In a highly competitive bidding war, KKR's offer of 9,850 yen per share ultimately prevailed.

CVS, Pharma Industry Clash With Pharmacy Benefit Managers

The pharmaceutical industry and pharmacy benefit managers (PBMs) are clashing in Washington, D.C., as the Trump administration takes shape. Drug companies are pushing to share negotiated savings with patients and hold PBMs accountable for limiting patient choices. PBMs, like CVS Caremark, defend their value in the healthcare system, but face scrutiny over their rebate strategy and whether it leads to higher out-of-pocket costs for patients. New models, such as Walmart's $4 generics, GoodRx coupons, and Cost Plus Drugs, offer low-cost prescription access, challenging the role of PBMs.

Herbalife Names New CEO, Marking New Chapter After Controversies

Herbalife appoints new CEO, Stephan Gratziani, as the company continues to revamp after past controversies

Trump Suggests Using Savings from Cost-Cutting Effort to Refund Taxpayers, Pay Down Debt

President Trump proposes returning some federal savings to taxpayers and reducing deficit through his DOGE (Department of Government Efficiency) effort, overseen by Elon Musk.

Top Miner Rio Backs Emissions Cuts, Says Greener Can Be Profitable

Rio Tinto, the world's second-largest mining company, supports corporate efforts to curb emissions, believing that pursuing green targets can add value.

Carvana Q4 Earnings Beat: Revenue and Profit Surge, Shares Dip Despite Record Sales

Carvana Reports Record Q4 Revenue and Profit, Exceeding Estimates; Shares Dip in After-Hours Trading